These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 31910629

  • 1. Proton Pump Inhibitor-Treated H. pylori Adjust Cell Envelope Fatty Acid and Cholesterol Content to Survive.
    Kadkhodaei S, Siavoshi F, Foroumadi A, Sarrafnejad A, Kolahdoozan S.
    Arch Iran Med; 2020 Jan 01; 23(1):7-14. PubMed ID: 31910629
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Influence of efflux pump inhibitors on the multidrug resistance of Helicobacter pylori.
    Zhang Z, Liu ZQ, Zheng PY, Tang FA, Yang PC.
    World J Gastroenterol; 2010 Mar 14; 16(10):1279-84. PubMed ID: 20222174
    [Abstract] [Full Text] [Related]

  • 5. Helicobacter pylori infection, chronic gastritis, and proton pump inhibitors.
    Dattilo M, Figura N.
    J Clin Gastroenterol; 1998 Mar 14; 27 Suppl 1():S163-9. PubMed ID: 9872516
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Relative potency of proton-pump inhibitors, Helicobacter pylori therapy cure rates, and meaning of double-dose PPI.
    Graham DY, Lu H, Dore MP.
    Helicobacter; 2019 Feb 14; 24(1):e12554. PubMed ID: 30440097
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori.
    Altintas E, Sezgin O, Ulu O, Aydin O, Camdeviren H.
    World J Gastroenterol; 2004 Jun 01; 10(11):1656-8. PubMed ID: 15162544
    [Abstract] [Full Text] [Related]

  • 11. Immunobiological effects of lipopolysaccharide derived from Helicobacter pylori and influence of a proton pump inhibitor lansoprazole on human polymorphonuclear leukocytes.
    Koshibu Y, Ubagai T, Yoshino Y, Ono Y.
    Folia Microbiol (Praha); 2024 Dec 01; 69(6):1369-1378. PubMed ID: 39153156
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Influence of various proton pump inhibitors on intestinal metaplasia in noneradicated Helicobacter pylori patients.
    Marusic M, Babic Z, Nesanovic M, Lucijanic-Mlinac M, Stajcar V.
    World J Gastroenterol; 2005 Apr 21; 11(15):2334-6. PubMed ID: 15818748
    [Abstract] [Full Text] [Related]

  • 16. Combination therapies with a proton pump inhibitor for Helicobacter pylori-infected gastric ulcer patients.
    Fukuda Y, Yamamoto I, Okui M, Tonokatsu Y, Shimoyama T.
    J Clin Gastroenterol; 1995 Apr 21; 20 Suppl 2():S132-5. PubMed ID: 7594330
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effects of unsaturated fatty acids on Helicobacter pylori in vitro.
    Khulusi S, Ahmed HA, Patel P, Mendall MA, Northfield TC.
    J Med Microbiol; 1995 Apr 21; 42(4):276-82. PubMed ID: 7707336
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Eradication of Helicobacter pylori with lansoprazole, amoxicillin, and plaunotol in duodenal ulcer patients.
    Shirai T, Takagi A, Kurumada T, Ohta U, Kobayashi H, Harasawa S, Miwa T.
    J Clin Gastroenterol; 1995 Apr 21; 20 Suppl 2():S128-31. PubMed ID: 7594329
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.